Fingerprint
Dive into the research topics of 'Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer
Tamara Muliaditan, James W. Opzoomer, Jonathan Caron, Mary Okesola, Paris Kosti, Sharanpreet Lall, Mieke Van Hemelrijck, Francesco Dazzi, Andrew Tutt, Anita Grigoriadis, Cheryl E. Gillett, Stephen F. Madden, Joy M. Burchell, Shahram Kordasti, Sandra S. Diebold, James F. Spicer, James N. Arnold*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
41
Citations
(Scopus)
299
Downloads
(Pure)